MetAlert (OTC: MLRT), a pioneer in location-sensitive, health-monitoring devices and wearable technology products for remote patient monitoring, is working with New-York-based Next Realm AI Research Lab to enhance predictive health solutions. According to the announcement, MetAlert will provide invaluable data from its current wearable technology suite to support Next Realm AI’s research projects. In addition, MetAlert will offer expertise to help identify and guide the best methods to harness this data; the collaboration will primarily focus on location-centric healthcare technology. Next Realm AI Research Lab is an artificial intelligence and data analytics research center. The announcement noted that the two companies hope to sculpt the blueprint for predictive models within the ever-evolving wearable health tech sector and will work to develop the framework for predictive health models utilizing data securely and privately aggregated from wearable tech devices. “Post the global pandemic, we’ve been exploring avenues to help improve and extend quality of life,” said MetAlert CEO Patrick Bertagna in the press release. “In this pursuit, AI is seemingly becoming a critical component, but to realize AI’s true potential, we need data. We believe data is this era’s new oil, and wearable technology is the invaluable vessel that can collect this data in real-time across the globe.”

To view the full press release, visit https://ibn.fm/j51Rs

About MetAlert Inc.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing and licensing products, services and intellectual property in the wearable technology, personal location, wandering assistive technology, and health-data collection and monitoring business. MetAlert’s versatile solutions meld effortlessly across a gamut of applications — from consumer-focused products to specialized platforms tailored for enterprise and governmental audiences. With years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer’s, dementia and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software and connectivity solutions, utilizing the latest in miniaturized, low-power consumption GPS, cellular, RF, NFC and BLE technologies, enabling caregivers to track and monitor patients in real-time. Known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack — MetAlert and its flagship product stands as the world’s premier invisible wearable monitoring solution, tailor-made for individuals vulnerable to wandering, a boon for caregivers of Alzheimer’s, dementia, autism and traumatic brain injury patients. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in more than 40 countries and is a U.S. military government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information about this company, please visit www.MetAlert.com.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork